线粒体Ca2+单载体依赖的能量功能障碍驱动心力衰竭中的过度缩
Hugo Alves-Figueiredo1,2,3, Christian Silva-Platas1, Manuel Estrada4
1Tecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, Cátedra de Cardiología y Medicina Vascular, Monterrey, NL, México.
JACC. Basic to translational science
|April 29, 2024
概括
线粒体单载体 (MCU) 通过引起细胞缩和能量问题来驱动心力衰竭. 阻止MCU可以防止这些问题,为心脏病提供潜在的治疗点.
科学领域:
- 心脏病学 心脏病学
- 线粒体生物学 线粒体生物学
- 分子医学是分子医学.
背景情况:
- 线粒体单载体 (MCU) 在心力衰竭 (HF) 病原发生过程中的作用尚不清楚.
- 过度缩小的心脏细胞表现出生物能功能障碍和MCU过度表达.
研究的目的:
- 调查MCU在血管素II (ANGII) 诱导的心脏缩和心力衰竭中的作用.
- 探索调节心脏缩中MCU表达的信号通路.
主要方法:
- 在细胞和小鼠模型中利用血管激素II (ANGII) 诱导心脏缩.
- 采用了MCU静音,成像,ROS检测和西部涂抹.
- 在人类心力衰竭患者样本和左心室辅助器件 (LVAD) 植入后分析了MCU表达.
主要成果:
- 沉默MCU通过阻止过载来防止ANGII诱导的细胞缩,线粒体功能障碍和炎症.
- 鉴定了Ca2+/calmodulin独立蛋白激酶II/循环腺单酸盐反应元素结合蛋白信号作为ANGII诱导的MCU上调调节的调节者.
- 在HF患者和人类HF患者的小鼠模型中观察到MCU表达的增加,与病理重塑相关.
- 在LVAD植入后显示MCU表达的减少,表明组织可塑性.
结论:
- 在心力衰竭中,MCU在调节心脏缩和生物能功能障碍方面发挥着至关重要的作用.
- 准MCU或其调节途径为心力衰竭提供了潜在的治疗策略.
相关概念视频
Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Imbalances in Cardiac Output
1.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
Cross-bridge Cycle
117.4K
As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
117.4K
Pathophysiology of Cardiac Performance
644
Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
644
Heart Failure Drugs: Inotropic Agents
574
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
574
Energy to Drive Translocation
2.1K
Mitochondrial protein import is powered by two distinct energy sources: ATP hydrolysis and electrochemical potential across the inner membrane. Newly synthesized precursors are bound by cytosolic chaperones of the Hsp70 family, which guide them to the import receptors on the mitochondrial surface. Utilizing the energy of ATP hydrolysis, Hsp70 chaperones transfer these precursors to the TOM receptors on the mitochondrial outer membrane.
Generally, polypeptides are unfolded by two distinct...
Generally, polypeptides are unfolded by two distinct...
2.1K


